Mechanism of vascular resistance changes produced in skin and muscle by halothane.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001158:Arteries / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D005121:Extremities / Q000187:drug effects; D005260:Female; D006221:Halothane / Q000008:administration & dosage / Q000494:pharmacology*; D006439:Hemodynamics; D008297:Male; D009132:Muscles / Q000098:blood supply*; D009474:Neurons / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010477:Perfusion; D012867:Skin / Q000098:blood supply*; D013564:Sympathetic Nervous System / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects*; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014667:Vasopressins / Q000494:pharmacology
D014662:Vasoconstrictor Agents; D014667:Vasopressins; D000804:Angiotensin II; D006221:Halothane; D009638:Norepinephrine